Beyond hormone therapy for prostate cancer with PARP inhibitors

Affiliations

Free article

Johann Sebastian de Bono et al. Cancer Cell. 2011.

Free article

. 2011 May 17;19(5):573-4.

doi: 10.1016/j.ccr.2011.05.003.

¹ Section of Medicine, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Sutton, Surrey, SM2 5PT, UK. johann.de-Bono@icr.ac.uk

No abstract available

Comment in

Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.
Brenner JC, Ateeq B, Li Y, Yocum AK, Cao Q, Asangani IA, Patel S, Wang X, Liang H, Yu J, Palanisamy N, Siddiqui J, Yan W, Cao X, Mehra R, Sabolch A, Basrur V, Lonigro RJ, Yang J, Tomlins SA, Maher CA, Elenitoba-Johnson KS, Hussain M, Navone NM, Pienta KJ, Varambally S, Feng FY, Chinnaiyan AM. Brenner JC, et al. Cancer Cell. 2011 May 17;19(5):664-78. doi: 10.1016/j.ccr.2011.04.010. Cancer Cell. 2011. PMID: 21575865 Free PMC article.